"Neuroleptic malignant syndrome" (NMS) derives from the French "syndrome malin des neuroleptiques" and was first described in 1960 by Delay [1] and colleagues in association with haloperidol.

Yet, clinicians treating persons with autism continue to prescribe older neuroleptic agents targeting ... of tardive dyskinesia and neuroleptic malignant syndrome. This article presents a model ...

Medically reviewed by Brigid Dwyer, MD Compazine (prochlorperazine) is a prescription drug approved for the treatment of ...

Since the severe, life-threatening forms of catatonia are infrequent, this book will serve as an excellent source for consultation when faced with neuroleptic malignant syndrome, delirious mania, ...

neuroleptic malignant syndrome and hypercatabolic syndrome. This important new series arises from a coordinated programme of the International Programme on Chemical Safety (IPCS) (ILO/UNEP/WHO) and ...

Oliver McGowan died after contracting Neuroleptic Malignant Syndrome in hospital The consultant who gave a teenager anti-psychotic drugs that have been linked to his death said she "might have ...

neuroleptic malignant syndrome. <6months: not recommended. ≥6months: Severe behavior disorders: 0.25mg/lb IM every 6–8 hrs if needed. Tetanus: 0.25mg/lb IM or IV (see literature) every 6–8 hrs.

Family Handout Oliver died in intensive care after contracting the rare condition Neuroleptic Malignant Syndrome Oliver, who was mildly autistic and had epilepsy and learning difficulties ...

Exclude neuroleptic malignant syndrome if fever or other symptoms occur. Diabetes. Monitor for hyperglycemia, hyperlipidemia: do fasting blood glucose and lipids testing initially and during therapy.